We and others have tested the neuroprotective effect of pioglitazone (Actos), a PPAR-γ agonist, in G93A SOD1 transgenic mouse model of ALS and found significant increase in survival of G93A SOD1 mice. Here, PPARG is linked to amyotrophic lateral sclerosis.